Rajasthan Royals sold for $1.65B to Mittal-Poonawalla consortiumA consortium led by the Mittal family and including Adar Poonawalla will acquire Rajasthan Royals for $1.65 billion. The Mittal family will...
04 May, 2026, 12.22 AM IST
ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwideCyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide aff...
27 Apr, 2026, 09.47 AM IST
Serum Institute says working to develop Monkeypox vaccineThe World Health Organisation on August 14 declared the Mpox outbreak a public health emergency of international concern. The move came aft...
20 Aug, 2024, 07.48 PM IST
Serum CEO acquires London house in year's 'biggest' dealAccording to sources quoted by the newspaper, while the Poonawalla family did not intend to relocate, the mansion would "serve as a base fo...
13 Dec, 2023, 06.12 AM IST
Adar Poonawalla to buy London property for Rs 1,440 crore, the second-most expensive ever soldIndian billionaire Adar Poonawalla is set to purchase a London mansion, Aberconway House, for £138 million (Rs 1,440 crore), marking the ci...
12 Dec, 2023, 03.25 PM IST
Serum Institute CEO Adar Poonawalla expects malaria vaccine supply-demand mismatch to end in 2024"We're expecting a final WHO approval in the coming months, after which we can roll it out," Poonawalla told Reuters in an interview, addin...
02 Oct, 2023, 09.02 PM IST
People fed up with Covid, no takers for boosters, SII not making Covishield since December 2021: Adar PoonawallaAccording to the Serum CEO, booster vaccines have no demand because of the "general lethargy among people and also because they are fed up ...
20 Oct, 2022, 07.12 PM IST
Wockhardt unit partners with SII subsidiary to set up vaccine manufacturing plant in UKThe collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable number of employment opportunities al...
21 Mar, 2022, 11.51 AM IST
Serum Institute buys 50% stake in packaging JV SCHOTT KaishaThe joint venture between Germany’s specialty glass company SCHOTT AG and Indian group Kaisha, manufactures pharma packaging products such ...
17 Aug, 2021, 01.02 PM IST
Covid-19: AstraZeneca sends legal notice to SII over delays in vaccine supplyThe notice comes after Serum Institute delayed shipment of vaccines to the UK, and later did not meet its obligations to other countries th...
08 Apr, 2021, 10.22 AM IST
Adar Poonawalla urges countries please be patient, Serum directed to prioritise India needs"Dear countries and governments, as you await #COVISHIELD supplies, I humbly request you to please be patient, @SerumInstIndia has been dir...
21 Feb, 2021, 02.22 PM IST
Antonio Guterres saddened by loss of life in fire at Serum Institute: UN spokespersonFive men died after a fire broke out in a five-storeyed under-construction building in the Serum Institute of India's Manjari premises in P...
22 Jan, 2021, 12.48 PM IST
Serum Institute fire: Rahul Gandhi urges state govt to provide necessary help to victims, kinFive persons died and nine were evacuated from a building in the Serum Institute of India's Manjari premises in Pune after a fire broke out...
21 Jan, 2021, 09.13 PM IST
Govt panel recommends marketing authorisation to Serum Institute’s Covishield vaccine"The Subject Expert Committee has recommended in favour of marketing authoritsation to SII’s vaccine but with certain conditions, a person ...
01 Jan, 2021, 06.52 PM IST
Serum Institute to launch Dengue Monoclonal in India in next two yearsScientific details of the vaccines remained unclear. However, the vaccine maker said it will begin registrations for the vaccine soon.
20 Aug, 2018, 04.12 PM IST
Cipla Ltd to market Serum Institute's paediatric vaccines in EuropeCipla has launched multiple respiratory products in Europe this year, and launch of some key inhalers is expected in 2015.
20 Nov, 2014, 12.53 PM IST
NeuClone to collaborate with Serum Institute of India; to supply drugs globallyNeuClone has retained licence to the jointly developed biosimilars for the developed markets of USA, Europe, Canada, Australia, Taiwan.
17 Jul, 2014, 01.15 PM IST